LOGIN
ID
PW
MemberShip
2024-11-03 12:54
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Product
Sell Saxenda directly after non-face-to-face treatment?
by
Jung, Heung-Jun
Jul 10, 2022 03:31pm
Can hospitals sell Saxenda, known as diet injections, directly to patients after non-face-to-face treatment? It is an expensive drug worth more than 100,000 won per unit and there is a high demand for purchase, so it is not prescribed for outpatients. The problem is that some hospitals sell and deliver directly to patients even in non-face-to
Product
¡°Need to raise awareness and seek early diagnosis of Sjogre
by
Eo, Yun-Ho
Jul 1, 2022 05:49am
¡°We can fully provide the standard of care at local rheumatoid clinics. Have trust and visit a local clinic near you.¡± If you are experiencing symptoms such as dry mouth, eyes, nose and mucous membrane, skin, or indigestion without underlying diseases or other medication histories for over 3 months but haven¡¯t found its cause, it can b
Product
Approval of OTC teleconference bending machine project
by
Kang, Shin-Kook
Jun 23, 2022 05:49am
OTC teleconference bending machine issue, which has been on hold for 10 years, has secured a bridgehead for entering the market under the new government deregulation stance. The Ministry of Science and ICT held an ICT regulatory sandbox review committee on the 20th and approved the OTC teleconference bending machine based on the MOHW's co
Product
Prescription of oral COVID-19 drugs drop to 1,800 last week
by
Kang, Shin-Kook
Jun 13, 2022 05:54am
Prescriptions of the oral COVID-19 treatments Paxlovid and Lagevrio have been rapidly decreasing in line with the decrease of confirmed COVID-19 cases in Korea. On the 10th, the Korea Disease Control and Prevention Agency announced that it had prescribed Paxlovid and Lagevrio to 1,800 patients during the past week. From 6:30 p.m. on
Product
The supply of Tylenol suspension has been postponed again
by
Kim JiEun
May 25, 2022 05:47am
The sale of children's Tylenol suspension will be extended further. The supplier originally promised to supply it in June, but it seems that it will not be available until August, two months later. Johnson & Johnson Korea recently sent an official letter to drug distributors on the "Delay Notice on the Supply Schedule of Children's Tylenol Suspe
Product
Unsure efficacy of Alzheimer's drug aducanumab
by
Choi-sun
May 10, 2022 06:07am
The Korean Dementia Association has reviewed the clinical potential of aducanumab (Aduhelm), the first new drug for Alzheimer's disease to be introduced to the field in 18 years. With the efficacy of the drug under constant debate, and being barely approved for its effect in reducing surrogate biomarkers such as amyloid reduction in Korea and
Product
Aftermath of Revlimid of primary benefit multiple myeloma
by
Whang, byung-woo
Apr 28, 2022 06:06am
As Revlimid (Lenalidomide Hemihydrate) based chemotherapy enters the benefit, changes in RRMM prescription patterns are inevitable. Kyprolis-centered KRd therapy (Carfilzomib+Revlimid+Dexamethasone) and Ninlaro-centered IRd therapy ( As both Ixazomib+Revlimid+Dexamethasone) contain Revlimid, there are concerns at the clinical site about how
Product
The KPA establishes an emergency TFT
by
Apr 20, 2022 06:05am
As the presidential transition committee is expected to include the permission of non-face-to-face medical treatment in its national agenda and fully review the revision of the law, the KPA has begun to come up with measures. The Chairman Choi Kwang-hoon formed a TFT related to non-face-to-face treatment and convened his first meeting toda
Product
Non-face-to-face tx companies are appealing for regulations
by
Jung, Heung-Jun
Apr 20, 2022 06:05am
Non-face-to-face treatment companies are appealing for regulatory improvement ahead of the abolition of social distancing and easing the level of infectious diseases. Pharmacists are protesting that the reason for non-face-to-face is disappearing and that they should take steps to temporarily terminate the permit as scheduled. According to th
Product
Immunity products fare better ¡°targeting the long COVID mkt
by
Apr 19, 2022 05:52am
The OTC drug trend at pharmacies is changing. Compared to February and March when the Omicron variant had wielded power over the country and sales at pharmacies increased due to a surge in demand for antipyretic analgesics and sore throat treatments, etc., sales of products related to long-term effects of COVID-19 are now increasing due to more
1
2
3
4
5
6
7
8
9
10
>